Elevation Oncology Reports Officer/Director Changes
| Field | Detail |
|---|---|
| Company | Elevation Oncology, Inc. |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, officer-appointment, director-election
TL;DR
Elevation Oncology just filed an 8-K detailing leadership changes and new compensation plans.
AI Summary
Elevation Oncology, Inc. filed an 8-K on April 1, 2025, reporting changes as of March 31, 2025. The filing indicates a departure of directors or certain officers, an election of directors, and the appointment of certain officers, along with details on compensatory arrangements for these officers. The company, formerly known as 14ner Oncology, Inc., is incorporated in Delaware and headquartered in Boston, Massachusetts.
Why It Matters
Changes in key leadership and officer compensation can signal shifts in company strategy or financial priorities.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially with new compensatory arrangements, can introduce uncertainty about future strategy and financial performance.
Key Players & Entities
- Elevation Oncology, Inc. (company) — Registrant
- 14ner Oncology, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Boston, Massachusetts (location) — Principal executive offices
- 001-40523 (filing_id) — SEC File Number
- 20250331 (date) — Date of earliest event reported
FAQ
What specific changes were made regarding directors or officers?
The filing indicates a departure of directors or certain officers, an election of directors, and the appointment of certain officers.
When were these changes effective?
The changes reported in the 8-K were effective as of March 31, 2025.
What is the former name of Elevation Oncology, Inc.?
The former name of Elevation Oncology, Inc. was 14ner Oncology, Inc., with a name change date of July 19, 2019.
Where are Elevation Oncology, Inc.'s principal executive offices located?
The principal executive offices are located at 101 Federal Street, Suite 1900, Boston, Massachusetts 02110.
What is the SEC file number for Elevation Oncology, Inc.?
The SEC file number for Elevation Oncology, Inc. is 001-40523.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Elevation Oncology, Inc..